$DECURE · Solana

One token. Three jobs.

Compute, direction and research. $DECURE rewards verified molecular work, lets holders steer attention across the twelve disease areas, and builds the budgets that pay for real experiments. Fixed supply of 1 trillion, minted once: 6% launches liquidity and 94% is the locked protocol reserve. No presale, no team allocation. Every future release splits 50% to the research vaults that pay laboratories, 30% to Proof-of-Folding and 20% to staking.

Genesis supply6% launch liquidity · 94% locked reserve
Coming soonProtocol token

$DECURE: one token, three jobs*

$DECURE gives the DeCure research loop an economy: it rewards verified molecular compute, lets holders direct attention across the twelve disease areas, and builds the budgets that pay for real experiments. It carries no equity, dividend, royalty or claim on a paper, patent or laboratory.

*“Trillion-dollar” describes the mission — channelling research money into drug repurposing published open-access. It is not a price target, forecast or promise about the token. No presale, no team allocation. $DECURE carries no equity, dividend, royalty or claim on revenue, papers or patents, and can lose all value.

PresaleNone
Launch liquidity6%
Locked reserve94%
Token classProtocol
Protocol token$DECURE rewards verified molecular compute, lets stakers direct research across the twelve disease areas, and builds the budgets that pay for experiments.
What it powersThe folding network, the twelve research vaults that pay laboratories, and the staking weight that decides how they are filled.
Genesis supply1 trillion minted once: 6% launches liquidity and 94% is the locked protocol reserve. Zero to founders, team, advisers or a presale.
Protocol objectives3
  • Build the twelve research vaults that finance wet-lab validation and publication — 50% of future protocol releases.
  • Reward verified Proof-of-Folding work — 30%.
  • Let stakers choose which disease areas receive more research attention — 20%.
How to get itNo presale

No presale, no private round, no whitelist. At launch you either buy it on the open market or you earn it by folding. It carries no equity, dividend, royalty or claim on papers or patents.

6% launch liquidity
94% locked protocol reserve
Protocol token